eight patients with osteogenic sarcoma and seven patients with ewing 's sarcoma , all with advanced metastatic disease refractory to conventional therapy , were treated with 5-azacytidine ( nsc-102816 ) intravenously at a dosage of 150 mg/m2 in three divided doses daily x 5 days .
C0029463
osteogenic sarcoma
C0553580
ewing 's sarcoma